These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22589524)

  • 21. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
    Huestis MA; Barnes A; Smith ML
    Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis effects on driving lateral control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    Drug Alcohol Depend; 2015 Sep; 154():25-37. PubMed ID: 26144593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.
    Lee D; Vandrey R; Milman G; Bergamaschi M; Mendu DR; Murray JA; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2013 Sep; 405(23):7269-79. PubMed ID: 23831756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The failings of
    Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
    Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
    Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Smoked Cannabis on Vigilance and Accident Risk Using Simulated Driving in Occasional and Chronic Users and the Pharmacokinetic-Pharmacodynamic Relationship.
    Hartley S; Simon N; Larabi A; Vaugier I; Barbot F; Quera-Salva MA; Alvarez JC
    Clin Chem; 2019 May; 65(5):684-693. PubMed ID: 30872375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.
    Gorelick DA; Goodwin RS; Schwilke E; Schwope DM; Darwin WD; Kelly DL; McMahon RP; Liu F; Ortemann-Renon C; Bonnet D; Huestis MA
    J Anal Toxicol; 2013; 37(1):11-6. PubMed ID: 23074216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis effects on driving longitudinal control with and without alcohol.
    Hartman RL; Brown TL; Milavetz G; Spurgin A; Pierce RS; Gorelick DA; Gaffney G; Huestis MA
    J Appl Toxicol; 2016 Nov; 36(11):1418-29. PubMed ID: 26889769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    JAMA Netw Open; 2018 Nov; 1(7):e184841. PubMed ID: 30646391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
    Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
    Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).
    Holland MG; Schwope DM; Stoppacher R; Gillen SB; Huestis MA
    Forensic Sci Int; 2011 Oct; 212(1-3):247-51. PubMed ID: 21764230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?
    Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Pope HG; Herning R; Cadet JL; Huestis MA
    Addiction; 2009 Dec; 104(12):2041-8. PubMed ID: 19804462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
    Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
    Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
    Pichini S; Mannocchi G; Berretta P; Zaami S; Pirani F; Pacifici R; Busardò FP
    Ther Drug Monit; 2020 Feb; 42(1):151-156. PubMed ID: 31389860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.